Pascal Soriot
Pascal Soriot | |
---|---|
Born |
Pascal Claude Roland Soriot 23 May 1959[1] |
Nationality | French |
Alma mater | École nationale vétérinaire d'Alfort[1] and HEC Paris |
Occupation | Businessman |
Years active | 1982–present |
Salary | GBP £3,507,000 (total compensation) [2] |
Title | CEO, AstraZeneca |
Term | 2012–2017 |
Successor | Incumbent |
Spouse(s) | married |
Children | 2 |
Pascal Claude Roland Soriot (born 23 May 1959) is the chief executive (CEO) of the Anglo-Swedish pharmaceutical multinational company AstraZeneca, since October 2012.[2]
In July 2017, it was reported that Soriot would become the next CEO of Israel-based Teva Pharmaceutical Industries, succeeding Erez Vigodman,[3][4] though this was soon refuted [5].
Early life
He studied veterinary medicine at university (École nationale vétérinaire d'Alfort at Maisons-Alfort in south-east Paris).[1] He later studied at HEC Paris.
Career
Roussel Uclaf
In April 1986, he joined Roussel Uclaf (formerly France's second largest pharmaceutical company, until bought by Hoechst AG in 1997)[6] as a salesman, where he lived in Australia.[1] In 1996 he became General Manager of Hoechst Marion Roussel in Australia, moving to Tokyo in April 1997
Aventis
In 2000 he moved to Aventis in America, becoming chief operating officer of Aventis USA in 2002, which became Sanofi Aventis USA in 2004.
Roche
He joined Roche in 2006. From April 2009 to 2010 he was chief executive of the Roche subsidiary Genentech. He rejoined Roche Pharma AG in 2010 as chief operating officer.[7]
AstraZeneca
In August 2012 he was named as the new chief executive of AstraZeneca,[8] the world's fifth largest pharmaceutical company, when aged 53. He took up the post on 1 October 2012.
Personal life
He is married with two children.[9]
References
- 1 2 3 4 "ascal Soriot: Leader of the great escape". Ft.com. Retrieved 26 January 2017.
- 1 2 "Executive Profile: Pascal Soriot". Bloomberg. Retrieved 3 April 2015.
- ↑ Reuters Editorial (14 May 2014). "AstraZeneca's CEO Soriot to join Israeli drugs company Teva: report". Reuters. Retrieved 12 July 2017.
- ↑ "Israeli newspaper reports that AstraZeneca CEO Pascal Soriot has agreed to take the helm at Teva – ENDPOINTS NEWS". Endpts.com. Retrieved 12 July 2017.
- ↑ {{url=http://www.telegraph.co.uk/business/2017/07/14/pascal-soriot-looks-set-stay-astrazeneca-chief/}}
- ↑ "Pascal Soriot". Roche.com. Retrieved 26 January 2017.
- ↑ "AstraZeneca Names Roche's Pascal Soriot as CEO". Bloomberg. Retrieved 6 February 2013.
- ↑ Rowley, Emma. "AstraZeneca appoints Roche's Pascal Soriot as new chief". Telegraph. Retrieved 26 January 2017.
- ↑ James Ashton (16 May 2014). "Astrazeneca chief Pascal Soriot: I can carry on curing the company, says scientist in £63bn bid battle". Standard.co.uk. Retrieved 26 January 2017.
External links
Business positions | ||
---|---|---|
Preceded by David Brennan |
Chief Executive of AstraZeneca 2012 – |
Succeeded by Incumbent |
Preceded by |
Chief Operating Officer of Hoffmann-La Roche 2010 – 2012 |
Succeeded by Daniel O'Day |
Preceded by |
Chief Executive of Genentech 2009 – 2010 |
Succeeded by Ian Clark |